Scalper1 News
Big pharma Valeant Pharmaceuticals (VRX) and Turing Pharmaceuticals face congressional subpoenas related to widening probes of why they raised prices sharply on life-saving drugs shortly after acquiring them. Meanwhile, the Senate’s Special Committee on Aging launched a probe into pharmaceutical pricing Wednesday and said it will seek related documents from four companies, including Valeant and Turing. Valeant said in a statement it will cooperate Scalper1 News
Scalper1 News